Home / Neumora Therapeutics, Inc. (NMRA)

Updated: 2026-03-17 00:38 UTC · Last close: 2.87 (-4.33%)

Neumora Therapeutics, Inc. (NMRA) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

Neumora Therapeutics, Inc. (NMRA) finished the session at 2.87 (-4.33%). Broadly speaking, trend structure still looks constructive because price remains above both the 50-day and 200-day averages. 20-day momentum is notably weak at -10.31%; price is trading in the upper part of its roughly 52-week range (0.62–3.59); and ATR14 volatility is elevated at roughly 9.21% of price. RSI(14) stands around 45.4, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Double top. The most important nearby levels are support at 2.78 and resistance at 2.89. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -177.48M · EPS (basic): -1.10. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

NMRA Chart